Healthcare - Industry Center - Yahoo Finance
- JNJThe Wall Street Journal•58 minutes ago
Johnson & Johnson said it raised the list price of its prescription medicines by an average of 8.5% last year—and 3.5% after discounts—in the health-products company’s first effort to address criticism ...
- BIIBTheStreet.com•4 hours ago
Perrigo also said it will review its API business, which provides differentiated active pharmaceutical ingredients and finished dosage forms for the branded and generic industries.